[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help] 

Status: Not Logged In; Sign In

How Romans Built Domes My 7 day suspension on X was lifted today. They Just Revealed EVERYTHING... [Project 2029] Trump ACCUSED Of MASS EXECUTING Illegals By DUMPING Them In The Ocean The Siege (1998) Trump Admin To BAN Pride Rainbow Crosswalks, DoT Orders ALL Distractions REMOVED Elon Musk Backing Thomas Massie Against Trump-AIPAC Challenger Skateboarding Dog Israel's Plans for Jordan Daily Vitamin D Supplementation Slows Cellular Aging: Hepatitis E Virus in Pork Hospital Executives Arrested After Nurse Convicted of Killing Seven Newborns, Trying to Kill Eight More The Explosion of Jewish Fatigue Syndrome Tucker Carlson: RFK Jr's Mission to End Skyrocketing Autism, Declassifying Kennedy Files Israel has killed 1,000 Palestinians in the West Bank since October 7, 2023 100m Americans live in areas with cancer-causing 'forever chemicals' in their water Scientists discover cancer-fighting bacteria that "soak up" forever chemicals in the body Israel limits entry of baby formula in Gaza as infants die of hunger 17 Ways mRNA Shots May CAUSE CANCER, According to Over 100 STUDIES Report: Pentagon Halts Some Munitions Shipments To Ukraine Over Concerns That US Stockpiles Are Too Low Locals Fear Demolitions as Israeli Troops Set Up New Base in Syrias Quneitra Russian forces discover cache of Ukrainian chemical drone munitions FSB Clarissa Ward: Gaza is what is turning people overseas against the US What Parents Wish Their Children Could Grow Up Without WHY SO MANY FOREIGN BASES IN AFRICA? Trump called Candace Owens about Brigitte Macron's P*NIS? New Mexico Is The Most-Dependent State On The Federal Govt, New Jersey The Least "This Is The Next Level": AI-Powered "Digital Workers" Deployed At Major Bank To Work Alongside Humans Cash Jordan: ICE Raids Taco Trucks... Deports 'Entire Parking Lot' of Migrants Jaguar Went Woke & The Results Were Catastrophic

Health
See other Health Articles

Title: Aust'n researchers prevent progression of diabetic kidney disease for first time
Source: [None]
URL Source: [None]
Published: Feb 10, 2017
Author: staff
Post Date: 2017-02-10 04:44:40 by Tatarewicz
Keywords: None
Views: 39
Comments: 1

SYDNEY, Feb. 10 (Xinhua) -- An Australian pharmaceutical company has successfully prevented the progression of Diabetic Kidney Disease (DKD) for the first time.

DKD is an often fatal long-term complication of type 2 diabetes which is the most common cause of severe renal disease. It affects one third of people with type 2 diabetes and has no viable treatment until now.

An international team of scientists in collaboration with Melbourne-based global biotechnology leader CSL Limited investigated a therapeutic approach that targets the transport of fatty acids, or lipids, from the blood into tissues to treat DKD.

Using 2H10, an antibody developed by CSL, the researchers were able to block Vascular Endothelial Growth Factor B (VEGF-B), a protein that affects the transport of lipids into body tissue. Elevated levels of VEGF-B are a common symptom among patients with DKD.

By inhibiting VEGF-B signalling the researchers were able to reduce the accumulation of lipid deposits within the kidney and moderate the progression of kidney disease in a number of models of type 1 and 2 diabetes.

Andrew Nash, Senior Vice President of Research at CSL, said the finding could save lives.

"This research addresses an important area of unmet medical need and could lead to an entirely new approach to the treatment of type 2 diabetes," Nash said in a media release on Friday.

Professor Ulf Eriksson, the lead researcher on the study, said that "the study reveals some mechanistic understanding of the disease progression and challenges the hypothesis that diabetic kidney disease is simply the result of chronic elevated blood glucose."

The study, which was published in respected journal Cell Metabolism on Friday, was carried out on mice but a human trial of the protein in humans with DKD has been flagged for the near future. Editor: ying

Post Comment   Private Reply   Ignore Thread  

Begin Trace Mode for Comment # 1.

#1. To: Tatarewicz (#0)

The study, which was published in respected journal Cell Metabolism on Friday, was carried out on mice but a human trial of the protein in humans with DKD has been flagged for the near future.

Can't come too soon.

sneakypete  posted on  2017-02-10   5:23:39 ET  Reply   Untrace   Trace   Private Reply  

        There are no replies to Comment # 1.

End Trace Mode for Comment # 1.

Top • Page Up • Full Thread • Page Down • Bottom/Latest

[Home]  [Headlines]  [Latest Articles]  [Latest Comments]  [Post]  [Sign-in]  [Mail]  [Setup]  [Help]